Nevirapine
- Strength
- 200 mg/1
- Form
- Tablet
- Class
- Human Immunodeficiency Virus 1 Non-Nucl…
Camber Pharmaceuticals, Inc.
Listed by Macleods Pharmaceuticals Limited
| Dosage form | Tablet, Extended Release |
|---|---|
| Route | Oral |
| Drug class | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 33342-238 |
| FDA application | ANDA206879 |
| RxNorm concept | 1095712 |
| Package sizes listed | 1 |
| Marketed since | October 2017 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Camber Pharmaceuticals, Inc.
Aurobindo Pharma Limited
Macleods Pharmaceuticals Limited
Mylan Pharmaceuticals Inc.
Mylan Pharmaceuticals Inc.
Amneal Pharmaceuticals LLC
Micro Labs Limited
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.